Annual Total Assets
$43.89 M
-$13.08 M-22.96%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual total assets is $43.89 million, with the most recent change of -$13.08 million (-22.96%) on April 30, 2024.
- During the last 3 years, IPA annual total assets has fallen by -$10.65 million (-19.53%).
- IPA annual total assets is now -39.35% below its all-time high of $72.36 million, reached on April 30, 2022.
Performance
IPA Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$43.11 M
+$298.90 K+0.70%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly total assets is $43.11 million, with the most recent change of +$298.90 thousand (+0.70%) on October 31, 2024.
- Over the past year, IPA quarterly total assets has increased by +$298.90 thousand (+0.70%).
- IPA quarterly total assets is now -40.43% below its all-time high of $72.36 million, reached on April 30, 2022.
Performance
IPA Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
IPA Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.0% | +0.7% |
| 3 y3 years | -19.5% | +0.7% |
| 5 y5 years | +107.5% | +0.7% |
IPA Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.4% | at low | -40.4% | +0.7% |
| 5 y | 5-year | -39.4% | +125.3% | -40.4% | +122.9% |
| alltime | all time | -39.4% | >+9999.0% | -40.4% | >+9999.0% |
ImmunoPrecise Antibodies Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $43.11 M(+0.7%) |
| Jul 2024 | - | $42.81 M(-2.5%) |
| Apr 2024 | $43.89 M(-23.0%) | $43.89 M(-25.2%) |
| Jan 2024 | - | $58.71 M(+7.4%) |
| Oct 2023 | - | $54.67 M(-5.4%) |
| Jul 2023 | - | $57.77 M(+1.4%) |
| Apr 2023 | $56.97 M(-21.3%) | $56.97 M(-7.5%) |
| Jan 2023 | - | $61.59 M(+1.3%) |
| Oct 2022 | - | $60.81 M(-1.4%) |
| Jul 2022 | - | $61.67 M(-14.8%) |
| Apr 2022 | $72.36 M(+32.7%) | $72.36 M(+63.6%) |
| Jan 2022 | - | $44.23 M(-9.1%) |
| Oct 2021 | - | $48.68 M(-5.7%) |
| Jul 2021 | - | $51.64 M(-5.3%) |
| Apr 2021 | $54.54 M(+180.0%) | $54.54 M(+59.9%) |
| Jan 2021 | - | $34.11 M(+4.0%) |
| Oct 2020 | - | $32.80 M(+31.7%) |
| Jul 2020 | - | $24.91 M(+27.9%) |
| Apr 2020 | $19.48 M(-7.9%) | $19.48 M(+0.7%) |
| Jan 2020 | - | $19.34 M(-3.4%) |
| Oct 2019 | - | $20.03 M(-5.5%) |
| Jul 2019 | - | $21.19 M(+0.2%) |
| Apr 2019 | $21.15 M(+10.6%) | $21.15 M(-3.9%) |
| Jan 2019 | - | $22.02 M(-7.0%) |
| Oct 2018 | - | $23.66 M(+29.1%) |
| Jul 2018 | - | $18.33 M(-4.2%) |
| Apr 2018 | $19.13 M(+563.9%) | $19.13 M(+80.4%) |
| Jan 2018 | - | $10.60 M(+2.6%) |
| Oct 2017 | - | $10.33 M(+328.1%) |
| Jul 2017 | - | $2.41 M(-16.3%) |
| Apr 2017 | $2.88 M(>+9900.0%) | $2.88 M(-17.5%) |
| Jan 2017 | - | $3.49 M(+781.5%) |
| Sep 2016 | - | $396.10 K(+2100.6%) |
| Jun 2016 | - | $18.00 K(-9.5%) |
| Mar 2016 | - | $19.90 K(+79.3%) |
| Dec 2015 | $11.10 K(-72.0%) | - |
| Dec 2015 | - | $11.10 K(-24.5%) |
| Sep 2015 | - | $14.70 K(-41.4%) |
| Jun 2015 | - | $25.10 K(-28.9%) |
| Mar 2015 | - | $35.30 K(-11.1%) |
| Dec 2014 | $39.70 K(-70.3%) | - |
| Dec 2014 | - | $39.70 K(-11.4%) |
| Sep 2014 | - | $44.80 K(-53.2%) |
| Jun 2014 | - | $95.80 K(-18.1%) |
| Mar 2014 | - | $117.00 K(-12.4%) |
| Dec 2013 | $133.60 K(+166.1%) | - |
| Dec 2013 | - | $133.60 K(-25.2%) |
| Sep 2013 | - | $178.60 K(+400.3%) |
| Jun 2013 | - | $35.70 K(-4.5%) |
| Mar 2013 | - | $37.40 K(-25.5%) |
| Dec 2012 | $50.20 K(-45.0%) | - |
| Dec 2012 | - | $50.20 K(-32.3%) |
| Sep 2012 | - | $74.20 K(-6.1%) |
| Jun 2012 | - | $79.00 K(-25.8%) |
| Mar 2012 | - | $106.40 K(+16.5%) |
| Dec 2011 | $91.30 K(-66.0%) | - |
| Dec 2011 | - | $91.30 K(-11.5%) |
| Sep 2011 | - | $103.20 K(-32.1%) |
| Jun 2011 | - | $151.90 K(-30.0%) |
| Mar 2011 | - | $217.10 K(-19.2%) |
| Dec 2010 | $268.60 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $268.60 K(-94.9%) |
| Sep 2010 | - | $5.27 M(+3.4%) |
| Jun 2010 | - | $5.10 M(-5.2%) |
| Mar 2010 | - | $5.38 M(+2.6%) |
| Dec 2009 | $5.25 M(-6.8%) | - |
| Dec 2009 | - | $5.25 M(-16.5%) |
| Sep 2009 | - | $6.28 M(+8.0%) |
| Jun 2009 | - | $5.81 M(+7.7%) |
| Mar 2009 | - | $5.40 M(-4.1%) |
| Dec 2008 | $5.63 M(+8.9%) | - |
| Dec 2008 | - | $5.63 M(-16.6%) |
| Sep 2008 | - | $6.75 M(+37.1%) |
| Jun 2008 | - | $4.92 M(+0.8%) |
| Mar 2008 | - | $4.88 M(-5.5%) |
| Dec 2007 | $5.17 M(+3.2%) | - |
| Dec 2007 | - | $5.17 M(-2.7%) |
| Sep 2007 | - | $5.31 M(+6.1%) |
| Jun 2007 | - | $5.01 M(+4.0%) |
| Mar 2007 | - | $4.82 M(-3.9%) |
| Dec 2006 | $5.01 M(+43.9%) | - |
| Dec 2006 | - | $5.01 M(-9.9%) |
| Sep 2006 | - | $5.56 M(+8.0%) |
| Jun 2006 | - | $5.15 M(+52.9%) |
| Mar 2006 | - | $3.37 M(-3.3%) |
| Dec 2005 | $3.48 M(-2.1%) | - |
| Dec 2005 | - | $3.48 M(-11.8%) |
| Sep 2005 | - | $3.95 M(+7.9%) |
| Jun 2005 | - | $3.66 M(+5.8%) |
| Mar 2005 | - | $3.46 M(-2.7%) |
| Dec 2004 | $3.56 M(+219.8%) | - |
| Dec 2004 | - | $3.56 M(+92.9%) |
| Sep 2004 | - | $1.84 M(+9.5%) |
| Jun 2004 | - | $1.68 M(+0.3%) |
| Mar 2004 | - | $1.68 M(+50.9%) |
| Dec 2003 | $1.11 M(+95.7%) | - |
| Dec 2003 | - | $1.11 M(-2.3%) |
| Sep 2003 | - | $1.14 M(+68.9%) |
| Jun 2003 | - | $674.00 K(+6.9%) |
| Mar 2003 | - | $630.60 K(+10.9%) |
| Dec 2002 | $568.40 K(+3.3%) | - |
| Dec 2002 | - | $568.40 K(-14.2%) |
| Sep 2002 | - | $662.30 K(-8.6%) |
| Jun 2002 | - | $724.70 K(+12.6%) |
| Mar 2002 | - | $643.50 K(+16.9%) |
| Dec 2001 | $550.50 K(-28.7%) | - |
| Dec 2001 | - | $550.50 K(-5.5%) |
| Sep 2001 | - | $582.70 K(-10.7%) |
| Jun 2001 | - | $652.80 K(-1.1%) |
| Mar 2001 | - | $660.00 K(-14.5%) |
| Dec 2000 | $772.20 K(+176.2%) | - |
| Dec 2000 | - | $772.20 K(+149.8%) |
| Sep 2000 | - | $309.10 K(+17.6%) |
| Jun 2000 | - | $262.80 K(+1.2%) |
| Mar 2000 | - | $259.60 K(-7.2%) |
| Dec 1999 | $279.60 K(-73.9%) | - |
| Dec 1999 | - | $279.60 K(-73.9%) |
| Dec 1998 | $1.07 M(-47.7%) | - |
| Dec 1998 | - | $1.07 M(-47.7%) |
| Dec 1997 | $2.04 M(-27.7%) | - |
| Dec 1997 | - | $2.04 M |
| Dec 1996 | $2.83 M | - |
FAQ
- What is ImmunoPrecise Antibodies annual total assets?
- What is the all time high annual total assets for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual total assets year-on-year change?
- What is ImmunoPrecise Antibodies quarterly total assets?
- What is the all time high quarterly total assets for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly total assets year-on-year change?
What is ImmunoPrecise Antibodies annual total assets?
The current annual total assets of IPA is $43.89 M
What is the all time high annual total assets for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual total assets is $72.36 M
What is ImmunoPrecise Antibodies annual total assets year-on-year change?
Over the past year, IPA annual total assets has changed by -$13.08 M (-22.96%)
What is ImmunoPrecise Antibodies quarterly total assets?
The current quarterly total assets of IPA is $43.11 M
What is the all time high quarterly total assets for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly total assets is $72.36 M
What is ImmunoPrecise Antibodies quarterly total assets year-on-year change?
Over the past year, IPA quarterly total assets has changed by +$298.90 K (+0.70%)